![Mark McCamish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark McCamish
Vorstandsvorsitzender bei
IconOVir Bio, Inc.
Profil
Mark A. McCamish is currently President & Chief Executive Officer at IconOVir Bio, Inc. Former positions include President, Chief Executive Officer & Director at Forty Seven LLC from 2017 to 2020; Director at Abbott Laboratories in 1997; Independent Director at Avadel Pharmaceuticals Plc from 2019 to 2026; Independent Director at Vincerx Pharma, Inc. from 2020 to 2021; Independent Director at Rafael Holdings, Inc. from 2021 to 2024; Chief Medical Officer & VP-Clinical Development at Perlegen Sciences, Inc. from 2003 to 2007; Global Head-Biopharmaceutical Development at Sandoz, Inc. from 2009 to 2017; Chief Medical Officer & Senior Vice President at Abbott Biotherapeutics Corp.
from 2008 to 2009; Professor at The Ohio State University; Professor at the University of California, Davis; and Chief Medical Officer & Senior Vice President at PDL BioPharma, Inc. from 2007 to 2008.
Education includes a doctorate from The Pennsylvania State University conferred in 1980; undergraduate and graduate degrees from the University of California, Santa Barbara in 1976 and 1977 respectively; and a doctorate from David Geffen School of Medicine.
Aktive Positionen von Mark McCamish
| Unternehmen | Position | Beginn |
|---|---|---|
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Vorstandsvorsitzender | 01.11.2020 |
Ehemalige bekannte Positionen von Mark McCamish
| Unternehmen | Position | Ende |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Direktor/Vorstandsmitglied | 12.02.2026 |
| RAFAEL HOLDINGS, INC. | Direktor/Vorstandsmitglied | 05.08.2024 |
| VINCERX PHARMA, INC. | Direktor/Vorstandsmitglied | 13.05.2021 |
| FORTY SEVEN, INC. | Vorstandsvorsitzender | 07.04.2020 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Corporate Officer/Principal | 01.04.2017 |
Ausbildung von Mark McCamish
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Discovers and develops drugs | Retail Trade |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes generic pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avadel Pharmaceuticals Plc
 Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Vincerx Pharma, Inc.
 Vincerx Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to address cancer | Health Technology |
